Health
Remyelinating drug shows potential to improve vision in patients with MS – News-Medical.Net
A team led by a biomedical scientist at the University of California, Riverside, reports a drug — an estrogen receptor ligand called indazole chloride (IndCl)…
A team led by a biomedical scientist at the University of California, Riverside, reports a drug — an estrogen receptor ligand called indazole chloride (IndCl) — has the potential to improve vision in patients with multiple sclerosis, or MS.
The study, performed on mice induced with a model of MS and the first to investigate IndCl’s effect on the pathology and function of the complete afferent visual pathway, is published in Brain Pathology. The afferent visual pathway includes the eyes, optic…
-
Noosa News20 hours agoHow Lily Steele-Park took her rapist to court and won
-
Noosa News20 hours agoE-biker charged with riding dangerously, assaulting cop
-
Noosa News23 hours agoStar’s Brisbane casino has been in the headlines for months: What’s the latest?
-
Business22 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025